The global gastrointestinal drugs market is expected to grow at a rate of 9%

Global Gastrointestinal Drugs Market Report 2022: Market Size, Trends and Forecast to 2026

The Business Research Company Global Gastrointestinal Drugs Market Report 2022: Market Size, Trends and Forecasts to 2026

LONDON, GREATER LONDON, United Kingdom, Oct. 13, 2022 / — According to The Business Research Company’s “Gastrointestinal Drugs Global Market Report 2022”, the gastrointestinal drugs market is expected to grow from $71.85 billion in 2021 to $75.63 billion in 2022 at a compound annual growth rate (CAGR) of 5.30%. The change in the growth trend of the gastrointestinal drugs market is mainly due to the companies stabilizing their production after meeting the demand which increased exponentially during the COVID-19 pandemic in 2020. of gastrointestinal drugs is expected to reach USD 105.51 billion in 2026 with a CAGR of 8.70%. The increase in the number of patients due to the increase in the geriatric population in the world will contribute significantly to the growth market during the forecast period.

Request a sample now to better understand the gastrointestinal drugs market:

Key trends in the gastrointestinal drug market
Major companies in the gastrointestinal drug industry are investing in the manufacture of oral capsules of macromolecular drugs for gastrointestinal diseases to make the drug more effective. Macromolecular drugs, such as peptides, proteins, and antibodies, form a new class of drugs that can treat diseases of the gastrointestinal tract, such as inflammatory bowel disease. These macromolecular drugs are typically injected and only a fraction of the administered dose reaches disease sites in the gastrointestinal tract. Thus, large companies like Eli Lilly are increasingly investing in the manufacture of oral capsules for macromolecular drugs. The company has invested $5 million to enter into a collaboration with Entrega to study the oral delivery of complex molecules, such as peptides to fight gastrointestinal diseases.

Gastrointestinal Drugs Market Overview
The gastrointestinal drugs market includes sales of gastrointestinal drugs by entities (organizations, independent marketers and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases such as ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation and irritable bowel syndrome. . The main categories of drugs for gastrointestinal diseases include antipeptic agents (antacids, antagonists, proton pump inhibitors, sucralfate and misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers , emollients/surfactants, hyperosmotics, saline solutions and simulants/irritants. .

To learn more about the Global Gastrointestinal Drugs Market report, visit:

TBRC Global Gastrointestinal Drugs Market Report 2022 covers the following insights:
Market Size Data
• Forecast period: historical and future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, United States, South America, Middle East and Africa.
• By country: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom, USA.

Market segmentation
• By type: antacids, antiulcers, vitamins and minerals, antiobesity, antiemetics and antinauseants, antidiarrheals
• By distribution channel: hospital pharmacies, retail pharmacies/pharmacies, other
• By route of administration: oral, parenteral, other
• By drug classification: brand name drugs, generic drugs
• By mode of purchase: prescription drugs, over-the-counter drugs
• By Geography: The global gastrointestinal drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest market share.

Major market players include Takeda Pharmaceuticals, Bayer AG, Abbott Laboratories, Otsuka Holdings Co ltd, Johnson & Johnson, Reckitt Benckiser Group plc, Bausch Health Companies Inc., Sanofi SA, Procter & Gamble, and Daiichi Sankyo Company.
Trends, opportunities, strategies and much more.

The Global Gastrointestinal Drugs Market Report 2022 is one of the comprehensive reports by The Business Research Company that provides an overview of the Gastrointestinal Drugs Market. Market report analyzes Gastrointestinal Drugs market size, Global Gastrointestinal Drugs market growth drivers, Global Gastrointestinal Drugs market segments, Global Gastrointestinal Drugs market major players , the growth of the global gastrointestinal drugs market in all geographies and the revenue and market positioning of the competitors of the gastrointestinal drugs market. The Gastrointestinal Drugs market report enables you to better understand the opportunities and strategies, as well as identify the countries and segments with the highest growth potential.

Not what you were looking for? Browse similar reports from The Business Research Company:
Global Antacids Market Report 2022

Global Gastrointestinal Devices Market Report 2022

Global Antidiarrheal Drugs Market Report 2022

About the business research company?
The Business Research Company has published over 3,000 industry reports covering over 3,000 market segments and 60 geographies. The reports are based on 150,000 datasets, extensive secondary research and proprietary insights from interviews with industry leaders. Reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Discover our:

Olivier Guirdham
The Business Research Society
+44 20 7193 0708
[email protected]
Visit us on social media:

Comments are closed.